MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe

25 Jul 2023 09:23:35 By Nasdaq GlobeNewswire

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

11 Jul 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US

29 Jun 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings

28 Jun 2023 14:05:41 By Nasdaq GlobeNewswire

Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

27 Jun 2023 08:00:01 By Nasdaq GlobeNewswire

Microbot Medical Expand IP protection in Japan

22 Jun 2023 08:36:38 By Nasdaq GlobeNewswire

Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe

16 Jun 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

06 Jun 2023 12:33:23 By Nasdaq GlobeNewswire

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

02 Jun 2023 12:36:53 By Nasdaq GlobeNewswire

Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

02 Jun 2023 08:16:15 By Nasdaq GlobeNewswire

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

31 May 2023 08:30:00 By Nasdaq GlobeNewswire

Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial

25 May 2023 08:40:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

24 May 2023 13:05:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 May 2023 15:24:08 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 May 2023 13:41:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

22 May 2023 15:18:00 By Nasdaq GlobeNewswire

Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians

22 May 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases

18 May 2023 09:15:00 By Nasdaq GlobeNewswire

Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System

08 May 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Final Data From Its Recent Animal Study

05 May 2023 09:00:00 By Nasdaq GlobeNewswire